Playback speed
10 seconds
Targeted Therapy for RET Fusion+ NSCLC: Efficacy Data for FDA Approved Selpercatinib & Pralsetinib
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
76 views
March 4, 2021
Comments 0
Login to view comments.
Click here to Login